Related Experiment Video
Updated: Jun 29, 2025

The Role of Indocyanine Green Fluorescence in Complex Laparoscopic Cholecystectomy Navigation
Published on: January 31, 2025
Acalculous Cholecystitis in COVID-19 Patients: A Narrative Review
Evanthia Thomaidou1, Eleni Karlafti2,3, Matthaios Didagelos1,4
1Department of Anesthesiology and Intensive Care Unit, AHEPA University General Hospital, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.
Acute acalculous cholecystitis (AAC), inflammation of the gallbladder without gallstones, is increasingly reported in COVID-19 patients. This review analyzes AAC
Area of Science:
- Gastroenterology and Hepatology
- Infectious Diseases
- Critical Care Medicine
Background:
- Acute acalculous cholecystitis (AAC) affects 5-10% of adult acute cholecystitis cases.
- Infectious agents can cause cholecystitis in healthy individuals.
- Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, impacts multiple organs, including the gastrointestinal tract via ACE2 receptors.
Purpose of the Study:
- To conduct a comprehensive literature review on acute acalculous cholecystitis (AAC) in patients with COVID-19.
- To analyze the pathogenesis, diagnosis, management, and outcomes of AAC associated with COVID-19.
Main Methods:
- Systematic review of existing literature.
- Analysis of case reports and clinical studies focusing on AAC in COVID-19 patients.
- Evaluation of diagnostic criteria and treatment strategies.
Main Results:
- AAC has been documented in patients with COVID-19.
- SARS-CoV-2 infection may contribute to AAC pathogenesis through gastrointestinal tract involvement.
- The review synthesizes current knowledge on AAC presentation and management in the context of COVID-19.
Conclusions:
- COVID-19 is an emerging risk factor for AAC.
- Understanding the link between SARS-CoV-2 and AAC is crucial for timely diagnosis and effective management.
- Further research is needed to elucidate the specific mechanisms and optimize treatment protocols for AAC in COVID-19 patients.
Related Concept Videos
Acute Pancreatitis II: Clinical Manifestations and Management
Chronic Pancreatitis II: Collaborative Care
Assessment:
Appendicitis-I: Introduction
Etiology: Appendicitis can arise from various causes, primarily rooted in the obstruction of the appendix lumen. Factors contributing to this obstruction include fecal accumulation, lymphoid hyperplasia and, in...
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Appendicitis-II: Diagnostic Studies and Management
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...

